1. Market Research
  2. > Cancer Industry

Ovarian Cancer Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Cancer, Diagnostics, Therapy, Cancer Diagnostic, Biopsy, Vaccine, Breast Cancer, Hospital, Pharmaceutical, Biomarker, Contraceptive, Feminine Hygiene, Genetic, Infectious Disease, Molecular Diagnostic, Prostate Cancer.


 
1-10 of 44 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: BRCA 1 & 2 Mutation in Cancer Forecast in 18 Major Markets 2017-2027

  • $ 6859
  • Industry report
  • June 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on BRCA1 and BRCA2 mutation in Cancer in 18 Major Markets It has long been established that BRCA1 and BRCA2 (BReast CAncer susceptibility ...

Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products fo ...

Ovarian Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of ...

OpportunityAnalyzer: Ovarian Cancer - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • May 2017
  • by GlobalData

OpportunityAnalyzer: Ovarian Cancer - Opportunity Analysis and Forecasts to 2025 Summary Ovarian cancer is the fifth most common malignancy in women and is the leading cause of death among gynecological ...

The 2018-2023 World Outlook for Ovarian Cancer Drugs and Diagnostics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

The 2018-2023 World Outlook for Ovarian Cancer Drugs

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

Global Ovarian Cancer Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • April 2017
  • by Currentpartnering

Provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Ovarian Cancer Partnering Terms ...

Ovarian Cancer Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

China’s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a ...

Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Ovarian Cancer Treatment Drugs Companies in China

  • $ 1800
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

About 4400 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Ovarian Cancer Statistics in the US and the UK

  • July 2017
    70 pages
  • Ovarian Cancer  

  • United States  

    United Kingdom  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.